$LIFE

Ethos Technologies Inc. (LIFE): Results of Operations and Financial Condition

Ethos Technologies Inc. (LIFE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 life-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Ethos Reports Second Quarter Fiscal Year 2026 Financial Results • Q2 Revenue grew 113% year-over-year to $190 million • Q2 Direct Channel Revenue grew 131% year-over-year to $116 million • Q2 Third-Party Revenue grew 90% year

Original reporting
Published Aug 3, 2026, 8:07 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 8:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$LIFE
Bullish
high confidence
Mentioned
$LIFE
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$LIFEBullishHigh
01

Why it matters

Traders can update valuation and positioning based on the disclosed Q3 and FY2026 revenue and Adj. EBITDA ranges, and the new $100M Class A buyback authorization.

02

Market read

Fresh earnings and guidance ranges plus a buyback authorization are immediate repricing inputs for LIFE.

03

What to watch

Non-GAAP metrics exclude items with high variability; GAAP reconciliation details are not fully shown in the excerpt, so investors may scrutinize sustainability of margins and cash conversion.

Relevance 7/10Novelty 9/10Timing: after-hours filing, guidance and buyback authorization disclosed today

Background

This is an SEC Form 8-K (Item 2.02) with Ethos’ Q2 FY2026 results and forward guidance, filed the same day as the press release.

Company-level read

Ticker impact

$LIFEBullishHigh confidence
Context

Ethos reported Q2 FY2026 revenue up 113% YoY to $189.6M, plus Q3 revenue guidance of $160M to $164M and Adj. EBITDA $23M to $25M.

Expected impact

Likely positive near-term bias if investors view guidance as credible and margins/EBITDA trajectory as sustainable.

Evidence & confidence

The filing discloses fresh, decision-relevant datapoints: Q2 results, forward guidance ranges, and a new buyback authorization, all of which can reprice expectations immediately.

Market effects

Reinforces demand and unit-economics momentum in life insurance technology distribution, potentially supporting sentiment for insurtech peers.

Limited direct regional spillover; primarily US-listed insurtech sentiment.

Low global macro linkage; mostly company-specific guidance and capital return.

Counterpoint

Revenue growth is strong, but average revenue per unit fell 8% YoY, which could signal mix shift or pricing pressure that may cap future profitability.

Key entities

  • Ethos Technologies Inc.

    Nasdaq-listed life insurance technology company reporting Q2 FY2026 results, issuing Q3 and FY2026 guidance, and authorizing a $100M share repurchase program.

  • Board of Directors

    Authorized a share repurchase program of up to $100 million of Ethos Class A common stock.

  • Peter Colis

    CEO and Co-Founder quoted on growth momentum and policy activations.

Related articles

$LIFEMed

Top SMid Cap Pick: Ethos Technologies Leads Citi’s Rankings

Citi analyst Ronald Josey named Ethos Technologies (LIFE) his top SMID-cap pick after the company’s Q2 results. Activated policies growth accelerated to 133% YoY, with 107,800 net activated policies. Revenue rose to $189.6M (+113% YoY). Ethos raised 2026 revenue guidance to $727M-$731M and adjusted EBITDA to $119M-$123M. Citi lifted its price target to $33 and kept Buy/High Risk.

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.